# One Network, Many Kinds of Evidence: A Critical Analysis

A critical analysis of Halama et al. (2024), *“A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes”* (*Nature Communications*), focused on multiomics integration, network-edge interpretation, and hypothesis generation.

---

## Table of Contents

* [Overview](#overview)
* [Objectives](#objectives)
* [Topics Covered](#topics-covered)
* [Repository Structure](#repository-structure)
* [Highlights](#highlights)
* [Skills Demonstrated](#skills-demonstrated)
* [Key Takeaways](#key-takeaways)
* [Future Work](#future-work)
* [References](#references)
* [Acknowledgements](#acknowledgements)
* [License](#license)

---

## Overview

This repository contains my second critical analysis paper, written as part of my bioinformatics research-reading portfolio.

The analysis examines a 2024 *Nature Communications* study that combined molecular measurements from 18 technically distinct analytical platforms. The research used data collected across a cohort of 391 participants in the Qatar Metabolomics Study of Diabetes, although participant coverage differed between platforms.

The authors connected genomic, methylation, transcriptomic, proteomic, glycomic, lipidomic, metabolomic, and clinical data to create an integrated network called “The Molecular Human.”

I selected this paper because I wanted to understand how different kinds of omics data are combined into one computational framework. What interested me most was that the final network contains edges produced by several statistical methods. These edges may look similar when displayed in the same network, but they do not necessarily provide the same kind of biological evidence.

This analysis is not a reproduction of the study or a new experiment. It is my written evaluation of the paper’s methodology, evidence, limitations, and possible extensions as a student developing skills in bioinformatics.

---

## Objectives

* Understand how the study integrated different types of omics data
* Examine what the different network edges represent
* Compare the meaning of GGM, MBH, GWAS, EWAS, and moTWAS results
* Evaluate differences in preprocessing and statistical thresholds
* Consider the effects of unequal participant coverage across platforms
* Discuss the interpretation of the diabetes-subtype networks
* Assess the availability of the study’s data and code
* Identify computational follow-up analyses suggested by the study

---

## Topics Covered

* Gaussian graphical models and partial correlations
* Mutual best hits between analytical platforms
* Genome-wide association studies
* Epigenome-wide association studies
* The paper-specific use of transcriptome-wide association analysis
* Multiomics network construction
* Multiple-testing correction
* Missing data and unequal platform overlap
* Immune-cell covariates and possible residual basophil confounding
* Type 2 diabetes subtype networks
* Cohort diversity and generalisability
* Data availability and computational reproducibility

---

## Repository Structure

```text
README.md
Critical_Analysis_2_The_Molecular_Human.pdf
```

* **Critical_Analysis_2_The_Molecular_Human.pdf** — the complete critical analysis, including diagrams, tables, methodological discussion, limitations, and possible research extensions.
* **README.md** — an overview of the repository and the purpose of the analysis.

---

## Highlights

The analysis follows the study from participant sampling and molecular profiling to statistical testing and network construction. It includes diagrams showing the main analytical pipeline, the different meanings of network edges, and the additional evidence required to move from a statistical association to a supported biological mechanism.

A major part of the analysis considers the difference between Gaussian graphical models and mutual best hits. The GGM analysis identifies conditional statistical relationships within individual platforms, while the MBH analysis identifies reciprocal correlations between platforms. These approaches were not processed in exactly the same way, so their resulting edges should not automatically be treated as equivalent evidence.

The analysis also examines the study’s GWAS, EWAS, and moTWAS results. In this paper, moTWAS refers to associations between directly measured RNA expression and other omics traits. This differs from the common use of TWAS for analyses based on genetically predicted gene expression.

Another section considers possible residual basophil confounding in part of the transcript–lipid analysis. The published models adjusted for several immune-cell populations, so this is not a general criticism of missing immune-cell adjustment. The remaining question is narrower because basophils were not listed as a separate covariate.

Finally, I discuss the study’s data and code availability. The public datasets, GitHub code, Docker image, and COmics interface make the project useful for further exploration. However, restricted access to individual-level genotype and methylation data limits complete independent reproduction of some parts of the analysis.

---

## Skills Demonstrated

* Literature Review
* Scientific Writing
* Critical Analysis
* Bioinformatics
* Multiomics Interpretation
* Statistical Network Interpretation
* Reproducibility Assessment
* Research Communication

---

## Key Takeaways

* A network edge must be interpreted according to the method that produced it.
* Partial correlation represents a conditional statistical relationship, but it does not prove a direct biochemical interaction.
* Mutual best hits can identify useful cross-platform relationships, but reciprocal correlation does not automatically establish molecular identity.
* Genetic, methylation, and transcript-expression associations do not provide identical evidence.
* Statistical association, biological plausibility, and demonstrated mechanism are different levels of evidence.
* Preprocessing and multiple-testing decisions affect which relationships are retained in a network.
* Participant coverage and sample overlap matter when integrating multiple analytical platforms.
* An exploratory network can be scientifically useful even when its individual edges still require further validation.

---

## Future Work

One follow-up project I would like to attempt is reconstructing a small part of the COmics network using the publicly available data and code.

I would select one molecule with a manageable number of connected features, identify the method that produced each edge, and compare the published mutual-best-hit approach with an alternative edge-selection rule. For example, I could test whether applying covariate adjustment before calculating between-platform correlations changes which edges are retained.

Other useful extensions could include:

* Testing whether selected MBH edges remain stable after covariate adjustment
* Examining the sensitivity of GGM edges to missing-data and imputation choices
* Testing whether transcript–lipid associations remain after explicitly accounting for basophil abundance
* Replicating selected network relationships in an independent cohort
* Adding clearer information about evidence type and validation status to network visualisations

These are proposed directions for future learning and analysis. They are not experiments that I have already completed.

---

## References

Halama, A., Zaghlool, S., Thareja, G., Kader, S., Al Muftah, W., Mook-Kanamori, M., Sarwath, H., et al. (2024). A roadmap to the molecular human linking multiomics with population traits and diabetes subtypes. *Nature Communications, 15*, 7111. https://doi.org/10.1038/s41467-024-51134-x

---

## Acknowledgements

This is an independent educational analysis written for my personal research portfolio. All scientific credit for the original study, its data, methods, and findings belongs to Halama et al. and the other contributing researchers.

This repository is not affiliated with or endorsed by the original authors or *Nature Communications*. Readers should consult the published article as the primary source for its methods, results, and conclusions.

---

## License

My original written analysis and repository text are shared under the [Creative Commons Attribution 4.0 International License](https://creativecommons.org/licenses/by/4.0/).

This licence applies only to the material I created. It does not apply to the original research article, its figures, its data, or other material owned by the authors, journal, or respective copyright holders.

---

**Repository description:**

An undergraduate critical analysis of Halama et al. (2024), examining multiomics integration, network-edge interpretation, statistical evidence, reproducibility, and hypothesis notes.

**Recommended GitHub topics:**

`bioinformatics` `computational-biology` `multiomics` `systems-biology` `type-2-diabetes` `network-analysis` `literature-review` `critical-analysis`

---

This repository is part of my ongoing effort to strengthen my understanding of bioinformatics and computational biology through structured critical reading.
